Vik Khurana is an attending neurologist at Massachusetts General Hospital and a Visiting Scientist at the Whitehead Institute for Biomedical Research at MIT.
BiographyVik Khurana is on the faculty at Harvard Medical School and Massachusetts General Hospital, and a Visiting Scientist at the Whitehead Institute for Biomedical Research. His clinical and research interests relate to neurodegenerative movement disorders, including Parkinson's disease, multiple system atrophy and the cerebellar ataxias. He is a medical graduate of the University of Sydney, Australia, and came to Boston as a Fulbright Scholar and Merck Company Foundation Fellow in 2001, obtaining his Ph.D. in neurobiology from Harvard University in 2006. He completed his residency in Neurology at Brigham and Women's and Massachusetts General Hospitals, and Fellowship training in Movement Disorders and Ataxia at Massachusetts General Hospital. His research efforts at the Whitehead Institute aim to develop novel therapies for neurodegenerative diseases by using diverse model systems including patient-derived stem cells. This work is supported by funding from the Howard Hughes Medical Institute and JPB Foundation, and a Clinician Scientist Development Award to Dr Khurana from the American Brain and Parkinson's Disease Foundations.
ResearchVik Khurana is interested in the molecular mechanisms underlying nerve cell death in neurodegenerative parkinsonism, ataxias and dementia. His interests include a disease called multiple system atrophy that can present with either parkinsonism or ataxia. The overarching goal of his research is to develop therapies tailored to individual patients. His research uses diverse model systems to understand these diseases and to test drugs and small molecules, from patient-derived human stem cells (induced pluripotent stem cells) to simpler systems including rodent neurons, fruit flies and yeast cells.
Phone 2: 617-726-3216